U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151482) titled 'Impact of Oral Supplementation With Bioactive Collagen Peptides and Other Functional Ingredients' on July 02.
Brief Summary: Genitourinary Syndrome of Menopause (GSM), characterized by vaginal dryness, pain, urinary incontinence, and other symptoms, can be mitigated through both hormonal and non-hormonal treatments. Collagen peptides have shown promising results in improving skin, cartilage, and exhibiting antioxidative activities in studies. This study evaluates changes of quality of life and sexual function, related to vulvovaginal atrophy (VVA) and initial urinary incontinence (UI) in women with GSM symptoms, with the intake of a...